Evidence map›Paper›PMID 26134948›Full record

ArticleThe Journal of investigative dermatology2015

IsaB Inhibits Autophagic Flux to Promote Host Transmission of Methicillin-Resistant Staphylococcus aureus.

Pei-Feng Liu, Jin-Shiung Cheng, Cheng-Len Sy, Wei-Chun Huang, Hsiu-Chen Yang, Richard L Gallo, Chun-Ming Huang, Chih-Wen Shu

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Autophagy and Bacterial infections.Autophagy reports · 2025
    Review
  3. Complement C3 deposition restricts the proliferation of internalizedFrontiers in cellular and infection microbiology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Selective Host Cell Death byFrontiers in immunology · 2020
    Review
  16. Review
  17. Article
  18. Frontiers in microbiology · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pei-Feng LiuDepartment of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Division of Dermatology, Department of Medicine, University of California, San Diego, San Diego, California, USA.
Jin-Shiung ChengDepartment of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Cheng-Len SyDepartment of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Wei-Chun HuangCardiovascular Medical Center, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Hsiu-Chen YangDepartment of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Richard L GalloDivision of Dermatology, Department of Medicine, University of California, San Diego, San Diego, California, USA; VA San Diego Healthcare Center, San Diego, California, USA.
Chun-Ming HuangDivision of Dermatology, Department of Medicine, University of California, San Diego, San Diego, California, USA. Electronic address: chunming@ucsd.edu.
Chih-Wen ShuDepartment of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

Funding

Cathelicidins in Skin ImmunityR01AI052453 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L, NIZET, VICTOR · 2002 to 2017
$5.3M
Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard L Gallo, Victor Nizet · 2019 to 2026
$4.6M
Skin barrier function and the microbiomeR01AI116576 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GALLO, RICHARD L, NAKATSUJI, TERUAKI · 2015 to 2019
$1.7M
Immunological Secretomes of the Early Anthrax InfectionR01AI067395 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI HUANG, CHUN-MING · 2006 to 2010
$1.2M
Anthrax vaccination by targeting spore germinationR21AI058002 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HUANG, CHUN-MING · 2004 to 2005
$726k
Indigenous Free Fatty Oleic acid Against MRSA Skin InfectionR21AI088147 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HUANG, CHUN-MING · 2010 to 2011
$460k
Acne Vaccines Targeting a Surface Sialidase and a Secreted CAMP Factor ToxinR41AR056169 · NIAMS · VAXIN INC. · PI HUANG, CHUN-MING · 2008 to 2008
$100k
NIAID NIH HHS R01 AI067395NIAID NIH HHS R01-AI067395-01NIAID NIH HHS R21 AI058002NIAID NIH HHS R21 AI088147NIAID NIH HHS R37 AI052453NIAMS NIH HHS 1R41AR056169NIAMS NIH HHS R41 AR056169PHS HHS R21-I58002-01PHS HHS R21-R022754-01
6 · The paper itself

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a major nosocomial pathogen that is widespread in both health-care facilities and in the community at large, as a result of direct host-to-host transmission. Several virulence factors are associated with pathogen transmission to naive hosts. Immunodominant surface antigen B (IsaB) is a virulence factor that helps Staphylococcus aureus to evade the host defense system. However, the mechanism of IsaB on host transmissibility remains unclear. We found that IsaB expression was elevated in transmissible MRSA. Wild-type isaB strains inhibited autophagic flux to promote bacterial survival and elicit inflammation in THP-1 cells and mouse skin. MRSA isolates with increased IsaB expression showed decreased autophagic flux, and the MRSA isolate with the lowest IsaB expression showed increased autophagic flux. In addition, recombinant IsaB rescued the virulence of the isaB deletion strain and increased the group A streptococcus (GAS) virulence in vivo. Together, these results reveal that IsaB diminishes autophagic flux, thereby allowing MRSA to evade host degradation. These findings suggest that IsaB is a suitable target for preventing or treating MRSA infection.

Indexed as

AnimalsAntigens, BacterialAutophagyCell SurvivalCross InfectionDisease Models, AnimalFemaleMethicillin-Resistant Staphylococcus aureusMiceMice, Inbred ICRRandom AllocationSensitivity and SpecificityStaphylococcus aureusVirulence FactorsAntigens, BacterialIsaB antigen, StaphylococcusVirulence Factors

Identifiers

PMID26134948
PMCPMC4641007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.